シンポジウム10 骨髄微小環境において骨髄腫細胞表面に発現する新たな治療標的分子

[SY10-4] Targeting B-cell maturation antigen with T-cell bispecific antibodies for the treatment of malignant plasma cell dyscrasias: preclinical and clinical development of EM801

Dirk Hose, Anja Seckinger (Universitaetsklinikum Heidelberg, Labor fuer Myelomforschung, Germany)

MILITARY SERVICE
10.1988-12.1989 3. FArt. Btl. 21, Schwalmstadt
HIGHER EDUCATION
10.1989-09.1996 Study of physics
04.1993-03.2002 Study of medicine
05.2007-11.2009 Doctoral thesis (Dr. med., Ruprecht-Karls-Universitaet Heidelberg)
08.2014-08.2015 Doctoral thesis (Dr. biol. hom, Justus-Liebig Universitaet Giessen)
07.2014 Habilitation (Priv.-Doz., Ruprecht-Karls-Universitaet Heidelberg)
PROFESSIONAL WORK AS PHYSICIAN AND SCIENTIST
05.2002- Dept. of Hematology, Oncology, and Rheumatology, UK Heidelberg
01.2006- Head of Multiple Myeloma Research Laboratory
AWARDS
05.2011 Young Investigator Award, XIIIth International Myeloma Workshop, Paris
09.2013 Ludwig Strauss Habilitation Award for research excellence (SFB/TRR79)
06.2018 Honorary Professorship (Prof. h.c.) University of Nanjing, China
MEMBERSHIPS
2007- Board of the German Speaking Myeloma Multicenter Group
2009- American Society of Hematology (ASH)
2015- International Myeloma Society (IMS)
2017- Deutsche Gesellschaft fr Hmatologie und Onkologie (DGHO)
2018- International Myeloma Working Group (IMWG)